DCGI approves Serum, Bharat Biotech vaccine for emergency use
Click here to read full article from source
New Delhi, Jan. 3 -- Eleven months after the first case of deadly coronavirus was detected in India, Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use, paving way for its roll-out and administration to millions.
"After adequate examination, the CDSCO has decided to accept the recommendations of the Subject Expert Committee and accordingly, vaccine of Serum and Bharat Biotech are being approved for restricted use in emergency situation," the Drugs Controller General of India Dr. V.G. Somani said.
Covishield and Covaxin have to be administered in two doses and can be stored at 2-8 degree Celsius. The Drugs Controller Gen...
To read the full article or to get the complete feed from this publication, please Contact Us